Foreign-invested pharmaceutical firms turn to pharmacy market

Published: 2002-08-08 07:00:00

Updated: 2002-08-08 07:00:00

Judging that the balanced development of ethicals and OTCs is essential for the company growth in the foreseeable future, many foreign pharmaceutical firms plan to expand their presence in the domestic pharmacy with their launching of new OTCs in a manner to less depend on their existing marketin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK